Oxford University and AstraZeneca vaccine trial shows up to 90 percent effectiveness Health Mojgan 24 November 2020 7 A COVID-19 vaccine developed by the UK’s Oxford University and AstraZeneca has an average efficacy of 70.4 percent, according to interim analysis announced today. In trials, the vaccine’s…